von der Grün, J.; Rödel, F.; Brandts, C.; Fokas, E.; Guckenberger, M.; Rödel, C.; Balermpas, P.
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? Cancers 2019, 11, 472.
https://doi.org/10.3390/cancers11040472
AMA Style
von der Grün J, Rödel F, Brandts C, Fokas E, Guckenberger M, Rödel C, Balermpas P.
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? Cancers. 2019; 11(4):472.
https://doi.org/10.3390/cancers11040472
Chicago/Turabian Style
von der Grün, Jens, Franz Rödel, Christian Brandts, Emmanouil Fokas, Matthias Guckenberger, Claus Rödel, and Panagiotis Balermpas.
2019. "Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?" Cancers 11, no. 4: 472.
https://doi.org/10.3390/cancers11040472
APA Style
von der Grün, J., Rödel, F., Brandts, C., Fokas, E., Guckenberger, M., Rödel, C., & Balermpas, P.
(2019). Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go? Cancers, 11(4), 472.
https://doi.org/10.3390/cancers11040472